Shamburg News · 8-K filed Oct 8, 2026, 8:38 AM EDT
Viatris agrees to acquire Pacira BioSciences for $36.50 per share in cash
VTRS · Viatris Inc
- Acquisition
- Material agreement
- Reg FD disclosure
- Materiality: high
On October 8, 2026, Viatris Inc. entered into an Agreement and Plan of Merger with Pacira BioSciences, Inc. and Peach Purchaser Sub Inc. Purchaser will commence a tender offer for all outstanding Pacira shares at $36.50 per share in cash, followed by a merger under Section 251(h) of the DGCL. The press release put the aggregate equity value at $1.65 billion and expected closing by the end of 2026. Pacira would owe Viatris a $62,000,000 termination fee under specified circumstances, and the offer is not subject to a financing condition.
Source: SEC EDGAR, Form 8-K, Items 1.01, 8.01, accession 0001140361-26-039024.
Written from the filing by Shamburg Markets. Figures are as reported by the company.